Plate Nº 94 · recorded October 7, 2026
Health & Medicine ResearchReported finding
Mystery Enzyme Identified After 30 Years — and It Shields Healthy Cells
After 33 years, MSK scientists identified gene DHRS7 as the maker of the alarm signal 5-oxoETE — and found the same pathway also shields healthy cells from immune attack.
By Marcus Bennett5 min read1,047 words
In brief
- A study published Oct. 7 in Nature identified gene DHRS7 as encoding a mystery enzyme first observed in 1992.
- The 5-oxoETE pathway both summons immune cells and protects healthy cells via NUDIX hydrolase enzymes.
- Mice lack the 5-oxoETE receptor, so the MSK team used zebrafish, whose version of human OXER1 is hcar1-4.
- OXER1 mutations correlate with poorer outcomes in colorectal, pancreatic and kidney cancers.
- Lower 5-oxoETE levels in intestinal tissue have been linked to worse outcomes in inflammatory bowel disease.
After more than 30 years, scientists have finally identified the gene behind a mystery enzyme — and in doing so discovered that a key inflammatory pathway doesn't just summon immune cells, it also shields healthy tissue from the immune system's own chemical attack.
The study, published Oct. 7 in Nature by a team at Memorial Sloan Kettering Cancer Center (MSK), solves a puzzle that dates to 1992 and opens new avenues for understanding diseases where inflammation runs out of control, including cancer, inflammatory bowel disease (IBD) and asthma.
What enzyme went unnamed for three decades?
The story began at McGill University in 1992, where researchers studied a fatty signaling molecule called 5-oxoETE — short for 5-oxo-6,8,11,14-eicosatetraenoic acid. This molecule acts as a chemical alarm that summons specialized white blood cells to the site of an infection.
The McGill team could see that an enzyme — a biological helper that speeds up chemical reactions — was building 5-oxoETE and breaking it down again. But they couldn't identify which human gene carried the blueprint for making it. Without the gene, they couldn't manipulate the enzyme in the lab, study its role in disease, or understand what happens when it fails. So they gave the enzyme a placeholder name based on its chemical reaction, and it kept that name for over 30 years.
Postdoctoral researcher Yanan Ma, Ph.D., of MSK's Sloan Kettering Institute — building on initial work by former labmate King Lam Hui, Ph.D. — finally unmasked it. After screening candidate genes in human cells, silencing each one in turn, she found that switching off a gene called DHRS7 stopped the enzyme's activity cold. The mystery enzyme had a name at last.
Why zebrafish and not mice?
Where other labs had pursued the pathway in mice, Ma's team chose zebrafish. That decision proved decisive.
"Mice and rats are the primary models used in biomedical research," said Ma, who received a Marie-Josée Kravis WISE Fellowship in 2023 for this work. "It makes sense — they're mammals, and there's about an 80% overlap between their genes and ours."
But mice lack a known receptor on their immune cells that 5-oxoETE can bind to.
"This means that you can't study the pathway in mice," Ma said. "But the pathway is intact in fish. So picking the right alternative model was critical to advancing our understanding of how the human body responds."
Consistent with that, the rodent version of DHRS7 showed almost no activity — exactly what you'd expect in an animal that has lost the receptor for the signal the enzyme produces.
Why did removing the alarm cause more inflammation?
The paper is unusual in another way: it fuses two separate projects. A second first author, postdoc Mikos Lengyel, M.D., Ph.D., had been working with a zebrafish model of colitis, knocking out genes to observe the effects.
When he disabled a gene called hcar1-4 — the zebrafish version of the human gene OXER1, which encodes the receptor that detects 5-oxoETE — something strange happened. The fish developed spontaneous gut inflammation with no infection present.
"So if you remove the receptor that detects the signal, you'd expect less inflammation, not more," Lengyel said.
It wasn't the neutrophils, the immune cells that normally rush in when the alarm sounds; depleting them didn't fix the problem. And when Lengyel silenced DHRS7 itself — no enzyme, no alarm signal — inflammation again increased.
"It made absolutely no sense," Lengyel said. "I had to prove it using several different methods before the rest of the lab was convinced."
What is the pathway's second job?
These paradoxical results led to the study's central finding: the pathway plays a protective role alongside its alarm function. Without the 5-oxoETE signal, or the Hcar1-4 receptor to receive it, the zebrafish's intestinal cells lost protection against low-level chemical stress caused by normal gut bacteria. The cells died, and that death triggered the inflammation the researchers observed.
The team traced this protection to a family of enzymes called NUDIX hydrolases, which work like a cleanup crew, removing damaged DNA building blocks before they cause harm.
"These immune cells unleash chemical warfare against a pathogen, and organisms have evolved an elegant way of protecting healthy cells at the same time," said lab leader Philipp Niethammer, Ph.D., who studies wound healing, inflammation and regeneration.
"As it turns out, this signal isn't just an alarm; it's also a shield," Niethammer said.
Could this lead to new treatments?
The researchers are cautious. The findings are preliminary and come largely from zebrafish, but the pathway is known to break down in several human diseases, and several hints connect it to patient outcomes:
- Mutations in DHRS7 and OXER1 appear in gastrointestinal and uterine tumors.
- Nonfunctional versions of OXER1 correlate with poorer outcomes in colorectal, pancreatic and kidney cancers.
- In IBD, lower levels of 5-oxoETE in intestinal tissue link to worse outcomes.
- In an independent primate study of asthma, blocking OXER1 dampened immune-cell responses but also wiped out protective mucus-producing cells lining the airway.
"More research is needed, but there's a possibility that activating the pathway could increase the resilience of the gut to oxidative stress — which might help counteract damage caused by radiation therapy or chemotherapy," Lengyel said.
What comes next?
The Nature paper captures only one side of the lab's work. Doctoral student Zaza Gelashvili, M.S., a co-author, studies the mechanical side: physical injury stresses cell membranes, releasing a fatty molecule called arachidonic acid — the raw material from which 5-oxoETE is built. His separate study on physical wound signals appeared in Nature Communications earlier this year.
"You can think of it as the first step in a chain reaction: Physical stress unlocks the raw material, oxidative stress drives the conversion, and DHRS7 amplifies the signal," Gelashvili said.
"What we are really studying is a pathway that integrates two completely different kinds of stress — mechanical and metabolic — and converts them into a single, coordinated, protective response," Niethammer said.
Publication details: Yanan Ma et al., "5-oxoETE links redox control of epithelial damage detection and resilience," Nature (2026). DOI: 10.1038/s41586-026-11121-2
via Medical Xpress (Source)
More from Marcus Bennett
Nearby plates
- Protective Enzyme UBE2N May Keep Fatty Liver Disease From Worsening
- Computer-Designed Protein Targets Immune Receptor at New 'Undruggable' Site
- Why a Food Poisoning Bacterium Can Also Cause Severe Wound Infections
- AI Searches Millions of Enzymes to Find Pollution Fighters
- When 'Healthy Fats' Undermine Cancer Immunity: Yale Study